130 related articles for article (PubMed ID: 32499915)
1. Prognostic significance of p16 protein in pancreatic ductal adenocarcinoma.
Iwatate Y; Hoshino I; Ishige F; Itami M; Chiba S; Arimitsu H; Yanagibashi H; Nagase H; Yokota H; Takayama W
Mol Clin Oncol; 2020 Jul; 13(1):83-91. PubMed ID: 32499915
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
[No Abstract] [Full Text] [Related]
4. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
7. Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma.
Chang DT; Chapman CH; Norton JA; Visser B; Fisher GA; Kunz P; Ford JM; Koong AC; Pai RK
Cancer; 2010 Nov; 116(22):5179-87. PubMed ID: 20665497
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract][Full Text] [Related]
10. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
APMIS; 2014 Dec; 122(12):1230-9. PubMed ID: 25053516
[TBL] [Abstract][Full Text] [Related]
12. [Expression of B cell transposition gene 3 in pancreatic ductal adenocarcinoma and its prognostic value].
Chen J; Zhou ZC; Liu WB; Wang J; Chen XJ; Shen YY; Zhong ZX
Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):863-867. PubMed ID: 29136736
[No Abstract] [Full Text] [Related]
13. Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma.
Attri J; Srinivasan R; Majumdar S; Radotra BD; Wig J
BMC Gastroenterol; 2005 Jun; 5():22. PubMed ID: 15985168
[TBL] [Abstract][Full Text] [Related]
14. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
16. P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.
Larque AB; Conde L; Hakim S; Alos L; Jares P; Vilaseca I; Cardesa A; Nadal A
Virchows Arch; 2015 Apr; 466(4):375-82. PubMed ID: 25652585
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
Pare R; Shin JS; Lee CS
Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
[TBL] [Abstract][Full Text] [Related]
18. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Zhou X; Wang X; Duan J; Sun W; Chen Z; Li Q; Ou Z; Jiang G; Ren X; Liu S
Pathol Res Pract; 2019 Feb; 215(2):343-346. PubMed ID: 30583814
[TBL] [Abstract][Full Text] [Related]
19. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes.
Schlitter AM; Segler A; Steiger K; Michalski CW; Jäger C; Konukiewitz B; Pfarr N; Endris V; Bettstetter M; Kong B; Regel I; Kleeff J; Klöppel G; Esposito I
Sci Rep; 2017 Feb; 7():41064. PubMed ID: 28145465
[TBL] [Abstract][Full Text] [Related]
20. Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma.
Wang L; Lu J; Wu H; Wang L; Liang X; Liang Z; Liu T
Diagn Pathol; 2017 May; 12(1):42. PubMed ID: 28558797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]